Islamic Republic Ministry of Health updated the “high risk” map for COVID-19 in Iran and downgraded most of the cities from the “red” status. According to the new coloring map, 7 cities located in Kurdistan, West Azerbaijan and Kermanshah are “red”, 108 are “orange”, 247 designated as “yellow” and 85 are in “blue” status.
Despite continuous warnings from health experts and alarming signs about the sixth wave of COVID-19 in Iran, the Islamic Republic held its religious gatherings for Arbaeen and last days of Safar. The impacts of those gatherings have already begun to manifest even in the manipulated data of the Ministry of Health. The natural decline in cases has slowed down and infection rate is rising again in some parts of the country. For example, Fars has warned about the rise and Ardabil officials report a flareup of hospitalizations.
On the other hand, the vaccination with “ineffective and unsafe” vaccines, especially for children 12-18 continues across Iran. Ministry of Health data indicate about 80% of shots used in Iran are the Chinese Sinopharm, and possibly the Wuhan one which is not approved by WHO either.
In the meantime, Islamic Republic officials issued an “emergency use” approval for Spikogen. Even though the regime classifies the vaccine as one of the “homegrown” ones, it is developed in Australia. It has not published its clinical trial results yet, but they are expected in November! According to Islamic Republic officials, it has shown 60-65% efficacy in preventing severe disease and death. However, just like COVIran Barekat, PastoCoVac, and Fakhra, the regime only cares about expanding its “vaccine basket” for political gains.
The Ministry of Health Spokesperson announced 233 have died of COVID-19 in the past 24 hours and 11,625 tested positive for the novel coronavirus, significant increase in both metrics from the days before, as shown by the growth factors on the graphs. Professor of Epidemiology at Tehran University believes these numbers must be multiplied by 7 and Civil Registration Organization data show more than 292,000 have died of the disease since February 202.
Total: 5,674,083 (+11,625)
Dead: 122,012 (+233)
Critical: 5,549 (-49)
Active Cases: 382,072 (-5,559)
Total Tests: 32,936,656
Cover: Milad Hamadi